[topsearch__bar__shortcode]

December 2020

Onconova Therapeutics, Inc. (NASDAQ: ONTX), stock rising above the skies in the pre-market

Onconova Therapeutics, Inc. (NASDAQ: ONTX), a biotechnology corporation dedicated to the research and production of innovative cancer therapy drugs surged over 31% at $0.38 in pre-market trading Tuesday, on no news. However, recently the company announced the registration with the U.S. of an Investigational New Drug (IND) application Food and Drug Administration (FDA) for the […]

Onconova Therapeutics, Inc. (NASDAQ: ONTX), stock rising above the skies in the pre-market Read More »

LOTZ Stock

Titan Pharmaceuticals, (TTNP) stock flying after reverse stock split

The South San Francisco-based development stage company, Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) skyrocketed over 2300% to trade at $4.0200 in pre-market session soon after the company reported that it has approved a 1-for-30 reverse stock split of the common stock of the Company by its Board of Directors, effective at 5:00 p.m. On Monday, November 30,

Titan Pharmaceuticals, (TTNP) stock flying after reverse stock split Read More »

AGTC Stock

Sundial Growers Inc. (SNDL) Stock Surging Over Marijuana Bill

Sundial Growers Inc. (SNDL) stock jumped over 30 percent in pre-market to reach over $0.95 price and saw over 96 percent gain yesterday trading session. After cannabis stocks began their post-election rally from the ashes yesterday, SNDL saw support ahead of votes this week on decriminalization in the U.S. The House reported a planned vote

Sundial Growers Inc. (SNDL) Stock Surging Over Marijuana Bill Read More »

SPIR Stock

Jaguar Health (JAGX) Spikes Above 70% following the announcement of its Novel Proprietary Drug for ‘Long-Hauler’ COVID-19 Patients

Jaguar Health has decided to develop and commercialize Crofelemer for the treatment of COVID-19 recovery patients suffering from long-term diarrhea. The study is planned to begin in Europe. Jaguar Health, Inc. (JAGX) stock is on a roll today after the company along with its wholly-owned subsidiary, Napo Pharmaceuticals announced that they are planning to develop

Jaguar Health (JAGX) Spikes Above 70% following the announcement of its Novel Proprietary Drug for ‘Long-Hauler’ COVID-19 Patients Read More »